Afya (NASDAQ:AFYA) Cut to Buy at Wall Street Zen

Wall Street Zen cut shares of Afya (NASDAQ:AFYA) from a strong-buy rating to a buy rating in a research note released on Saturday morning.

Other equities research analysts have also recently issued research reports about the company. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a report on Wednesday, October 8th. UBS Group raised Afya from a “neutral” rating to a “buy” rating and decreased their price target for the stock from $19.50 to $19.00 in a research note on Monday, September 8th. Finally, JPMorgan Chase & Co. raised shares of Afya from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $23.50 to $24.50 in a research note on Monday, September 8th. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $18.75.

Afya Stock Up 1.7%

Shares of NASDAQ AFYA opened at $14.81 on Friday. The firm has a market cap of $1.39 billion, a P/E ratio of 10.65, a price-to-earnings-growth ratio of 0.51 and a beta of 0.52. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 0.98. Afya has a 1 year low of $13.47 and a 1 year high of $19.90. The firm’s 50 day moving average price is $14.66 and its 200 day moving average price is $15.39.

Institutional Investors Weigh In On Afya

Large investors have recently made changes to their positions in the business. Doma Perpetual Capital Management LLC lifted its holdings in shares of Afya by 50.6% during the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after acquiring an additional 299,419 shares in the last quarter. SPX Gestao de Recursos Ltda purchased a new position in Afya in the third quarter valued at about $2,895,000. Carrera Capital Advisors acquired a new position in shares of Afya during the second quarter worth about $1,750,000. Swedbank AB purchased a new stake in shares of Afya in the third quarter worth about $1,092,000. Finally, Jump Financial LLC purchased a new stake in shares of Afya in the second quarter worth about $731,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.